NYSE:ANTM - Anthem Stock Price, Forecast & News

Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."

Anthem declared a quarterly dividend on Thursday, January 30th. Investors of record on Monday, March 16th will be given a dividend of $0.95 per share on Friday, March 27th. This represents a $3.80 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date of this dividend is Friday, March 13th. This is an increase from Anthem's previous quarterly dividend of $0.80. View Anthem's Dividend History.

Anthem Inc (NYSE:ANTM) issued its quarterly earnings results on Wednesday, January, 29th. The company reported $3.88 EPS for the quarter, missing the consensus estimate of $3.90 by $0.02. The business earned $27.13 billion during the quarter, compared to analysts' expectations of $27.06 billion. Anthem had a net margin of 4.61% and a return on equity of 16.34%. The firm's revenue for the quarter was up 16.4% compared to the same quarter last year. During the same period last year, the business posted $2.44 earnings per share. View Anthem's Earnings History.

Anthem is scheduled to release their next quarterly earnings announcement on Wednesday, April 22nd 2020. View Earnings Estimates for Anthem.

Anthem updated its FY 2020 Pre-Market earnings guidance on Wednesday, January, 29th. The company provided earnings per share (EPS) guidance of 22.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $22.71. The company issued revenue guidance of $117-117 billion, compared to the consensus revenue estimate of $115.28 billion.

14 equities research analysts have issued 12 month price targets for Anthem's stock. Their forecasts range from $262.00 to $391.00. On average, they expect Anthem's share price to reach $332.83 in the next year. This suggests a possible upside of 12.8% from the stock's current price. View Analyst Price Targets for Anthem.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anthem in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Anthem.

Headlines about ANTM stock have been trending negative this week, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Anthem earned a daily sentiment score of -2.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Anthem.

Anthem saw a increase in short interest in January. As of January 15th, there was short interest totalling 4,400,000 shares, an increase of 13.1% from the December 31st total of 3,890,000 shares. Based on an average daily trading volume, of 1,420,000 shares, the days-to-cover ratio is presently 3.1 days. Currently, 1.7% of the shares of the stock are sold short. View Anthem's Current Options Chain.

Some companies that are related to Anthem include UnitedHealth Group (UNH), Cigna (CI), Humana (HUM), Centene (CNC), WellCare Health Plans (WCG), Molina Healthcare (MOH), Magellan Health (MGLN) and Triple-S Management (GTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Anthem investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Alibaba Group (BABA), Boeing (BA), Visa (V), Netflix (NFLX), AT&T (T), Bank of America (BAC) and CVS Health (CVS).

Anthem's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Wealth Quarterback LLC (14.49%), State Street Corp (4.35%), Capital International Investors (2.75%), Baillie Gifford & Co. (1.63%), Geode Capital Management LLC (1.47%) and Alliancebernstein L.P. (1.22%). Company insiders that own Anthem stock include Brian T Griffin, Craig E Samitt, Gail Boudreaux, Gloria M Mccarthy, John E Gallina, Joseph Swedish, Julie A Hill, Peter D Haytaian, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek and Thomas C Zielinski. View Institutional Ownership Trends for Anthem.

ANTM stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Barrow Hanley Mewhinney & Strauss LLC, Janus Henderson Group PLC, MUFG Americas Holdings Corp, CI Investments Inc., First Hawaiian Bank, UBS Asset Management Americas Inc. and Assenagon Asset Management S.A.. Company insiders that have sold Anthem company stock in the last year include Gloria M Mccarthy, Peter D Haytaian, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek and Thomas C Zielinski. View Insider Buying and Selling for Anthem.

ANTM stock was acquired by a variety of institutional investors in the last quarter, including Wealth Quarterback LLC, Capital International Investors, Artisan Partners Limited Partnership, M&G Investment Management Ltd., First Eagle Investment Management LLC, Sanders Capital LLC, Toronto Dominion Bank and Partner Fund Management L.P.. View Insider Buying and Selling for Anthem.

Shares of ANTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ANTM stock can currently be purchased for approximately $294.97.

Anthem has a market capitalization of $74.79 billion and generates $104.21 billion in revenue each year. The company earns $4.81 billion in net income (profit) each year or $19.44 on an earnings per share basis. Anthem employs 63,900 workers across the globe.View Additional Information About Anthem.

The official website for Anthem is http://www.antheminc.com/.

Anthem's mailing address is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. The company can be reached via phone at 800-331-1476 or via email at [email protected]